Targeting LRBA triggers CTLA4 degradation and antitumor immunity for cancer immunotherapy.
靶向 LRBA 可触发 CTLA4 降解和抗肿瘤免疫，用于癌症免疫疗法。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-67365-5
Ge Xiaolu, Yu Liang, Zhang Lei, Jia Liqing, Meng Mingjing, He Jingquan, Bu Fan, Song Yue, Sun Gaorui, Lv Shiming, Mei Desheng, Yang Yutao, Xu Dakang, Zhang Jingfa, Zhang Shengping, Wang Chuangui, Jia Deshui, Chen Yongping, Gao Yue, He Baokun
